Results 161 to 170 of about 27,286 (175)
Some of the next articles are maybe not open access.

AS1411 aptamer tagged PLGA‐lecithin‐PEG nanoparticles for tumor cell targeting and drug delivery

Biotechnology and Bioengineering, 2012
Abstract Liposomes and polymers are widely used drug carriers for controlled release since they offer many advantages like increased treatment effectiveness, reduced toxicity and are of biodegradable nature. In this work, anticancer drug‐loaded PLGA‐lecithin‐PEG nanoparticles (NPs) were synthesized and were functionalized with AS1411 ...
Athulya, Aravind   +7 more
openaire   +2 more sources

Anti-nucleolin aptamer-guided anticancer activity of AS1411-Chalcone conjugate in breast cancer

Biochemical and Biophysical Research Communications
The DNA aptamer AS1411 is a 26-nucleotide, guanine-rich oligonucleotide with high specificity for nucleolin-a multifunctional protein overexpressed on the surface of many cancer cells and involved in key processes such as proliferation and apoptosis. By selectively binding nucleolin, AS1411 serves as an ideal targeting ligand for delivering therapeutic
Vijay Murali Ravi Mythili   +8 more
openaire   +2 more sources

Erianin-Loaded AS1411 Aptamer–Albumin Nanoparticles Enhance Antiesophageal Cancer Efficacy by Inducing Ferroptosis

ACS Applied Materials & Interfaces
Esophageal cancer (EC) has a high incidence and mortality worldwide with a poor prognosis, and using targeted nanopreparations to treat EC is a promising therapeutic strategy. In this study, a drug delivery carrier AS1411-bovine serum albumin (BSA) that targets EC cells was prepared by conjugation technology.
Junqi Hou   +5 more
openaire   +2 more sources

AS1411: Development of an Anticancer Aptamer

2008
Nigel Courtenay-Luck, Donald M. Miller
openaire   +1 more source

Tumor Targeting With a 99mTc-Labeled AS1411 Aptamer in Prostate Tumor Cells

Journal of Drug Targeting, 2015
Seyed Jalal Hosseinimehr   +2 more
exaly  

A Phase II Trial of AS1411 (a Novel Nucleolin-Targeted DNA Aptamer) in Metastatic Renal Cell Carcinoma

Investigational New Drugs, 2014
Eliezer Van Allen   +2 more
exaly  

Home - About - Disclaimer - Privacy